Products

What will AGI do for Bivalirudin?

This classification denotes an anticoagulant agent with the molecular formula C98H138N24O33, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TN9BEX005G, chemically known as l-leucine, d-phenylalanyl-l-prolyl-l-arginyl-l-prolylglycylglycylglycylglycyl-l-asparaginylglycyl-l-alpha-aspartyl-l-phenylalanyl-l-alpha-glutamyl-l-alpha-glutamyl-l-isoleucyl-l-prolyl-l-alpha-glutamyl-l-alpha-glutamyl-l-tyrosyl- but generally known as bivalirudin, which bears US NIH Compound Identifier 16129704. European Medicines Agency schedules Bivalirudin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05862MIG. The term BIVALIRUDIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules bivalirudin in its Anatomical Therapeutic Chemical (ATC) Classification. BIVALIRUDIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bivalirudin under HS 29339990 and SITC 51577. As of Q4 2014, BIVALIRUDIN remains the US FDA Preferred Term for this commodity. Bivalirudin bears US NLM identifiers UMLS ID C0168273 and NCI Concept Code C47415. SMILES: O=C(N1C(CCC1)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1CCC(O)CC1)C(=O)NC(CC(C)C)C(=O)O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C1N(CCC1)C(=O)C(NC(=O)C1N(CCC1)C(=O)C(N)CC1CCCCC1)CCCNC(=N)N)CC(=O)N)CC(=O)O)CC1CC.